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Abstract
The var gene family of Plasmodium falciparum encodes the immunodominant variant surface antigens PfEMP1. These highly
polymorphic proteins are important virulence factors that mediate cytoadhesion to a variety of host tissues, causing
sequestration of parasitized red blood cells in vital organs, including the brain or placenta. Acquisition of variant-specific
antibodies correlates with protection against severe malarial infections; however, understanding the relationship between
gene expression and infection outcome is complicated by the modular genetic architectures of var genes that encode
varying numbers of antigenic domains with differential binding specificities. By analyzing the domain architectures of fully
sequenced var gene repertoires we reveal a significant, non-random association between the number of domains
comprising a var gene and their sequence conservation. As such, var genes can be grouped into those that are short and
diverse and genes that are long and conserved, suggesting gene length as an important characteristic in the classification of
var genes. We then use an evolutionary framework to demonstrate how the same evolutionary forces acting on the level of
an individual gene may have also shaped the parasite’s gene repertoire. The observed associations between sequence
conservation, gene architecture and repertoire structure can thus be explained by a trade-off between optimizing within-
host fitness and minimizing between-host immune selection pressure. Our results demonstrate how simple evolutionary
mechanisms can explain var gene structuring on multiple levels and have important implications for understanding the
multifaceted epidemiology of P. falciparum malaria.
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Introduction
The malaria parasite Plasmodium falciparum continues to be a
major public health problem globally [1,2,3]. In malaria-endemic
regions, repeated infections by genetically diverse parasites
continue into adulthood, and clinical protection appears to rely
on the gradual acquisition of variant-specific immunity to
polymorphic antigens [4,5,6]. The major target for this protective
immunity is thought to be PfEMP1 (Plasmodium falciparum
erythrocyte membrane protein 1), expressed on the surface of
infected red blood cells (iRBC) and encoded by the var multi-gene
family. PfEMP1 mediates adhesion to a variety of host receptors
on the endothelium as well as to uninfected red blood cells, leading
to the sequestration of parasitized cells in peripheral blood vessels
and organs [7,8,9,10,11]. This prevents the parasite from being
cleared by the spleen [12,13], however it is also associated with a
range of severe disease pathologies [14,15,16]. Switches in
expression between the parasite’s repertoire of ,60 var genes
during within-host antigenic variation, a process which facilitates
immune evasion, may therefore alter its binding phenotype and
consequently the pathology of infection [17,18,19]. The relation-
ship between mechanisms of acquired immunity, disease out-
comes, and the evolution and structure of these antigens are still
poorly understood, despite the critical role these interactions play
in shaping the epidemiology of malaria.
One of the most striking characteristics of PfEMP1 is the large,
variable domain structure of the extracellular portion of the
protein [20]. Var genes are characterised by variable numbers of
diverse Duffy Binding Like (DBL) domains and Cysteine-rich
InterDomain Regions (CIDRs), which can be further divided into
a number of subclasses, arranged in different combinations (see
schematic in Figure 1). The extremely high diversity of var gene
sequences, generated by means of recombination within and
between genomes [21,22], has made it difficult to analyse the
structure of individual parasite var repertoires and the parasite
population as a whole. Due to the difficulty in designing suitable
primers, var genes have traditionally been grouped according to
upstream promoter regions (Ups) A, B, and C, roughly
corresponding to the direction of transcription and the chromo-
somal location [23], as well as short sequence fragments within the
relatively conserved N-terminal DBLa domain [24]. Recently,
however, whole var repertoires from seven genomes have been
sequenced, revealing a remarkable variety of PfEMP1 structures
while confirming that repertoires from geographically diverse
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parasites are nonetheless structured in a similar way [25]. A classic
example of this shared structure is the preservation of one or two
copies of var2csa, which encodes a PfEMP1 variant that specifically
mediates binding to placental Chondroitin Sulfate A [26,27] and
has been found in every parasite genome studied to date. The
remaining var gene repertoire is composed of a mixture of long
(primarily Ups group A) and short (mostly Ups group B and C) var
genes in approximately similar proportions, as shown in Figure 1a
and b.
The specialization of var2csa for a particular ecological niche has
led to the idea that the composition of each repertoire with respect
to the other groups of var genes may reflect similar specialization
for different host niches and binding phenotypes. For example,
UpsB and UpsC genes have been shown to bind ICAM1 and
CD36, mediated by DBLbC2 [28] and CIDRa domains [29],
respectively, whereas in field isolates UpsA genes (and some
ICAM1 binders) are involved in the binding to uninfected
erythrocytes [30] via the DBL1a domain to Complement
Receptor-1 (CR1) [31], a process known as rosetting and
implicated in severe malarial disease among young children
[32]. This suggests that specific genes are adapted to particular
host niches, with certain domains within those genes being
responsible for the specific binding properties. However, the
specialization of individual domains for particular host receptors,
rather than entire genes, raises important questions about the
structuring and evolution of variable domain architectures.
Specifically, how does the structure of domains within var genes
relate to var genome repertoires and parasite fitness, and what
evolutionary processes can account for this structuring?
There are two important but largely unexplored aspects of var
genes which make them unusual in the context of host-pathogen
systems. First, most theoretical models of pathogen population
structure consider (immune) selection operating on a between-host
level through cross-immunity that depends on a degree of
antigenic similarity or overlap between pathogenic variants
[33,34,35,36]. Under these assumptions pathogens will evolve to
minimise immunological interference, favouring variants with
fewer antigenic targets. The large modular domain architecture of
var genes is therefore difficult to explain, considering that each
domain presents an additional target to the immune system and
that PfEMP1 plays a key role in both immune evasion and
naturally acquired immunity. Although the exact mechanisms of
immune protection to malaria are still unclear, antibodies to
PfEMP1 are thought to generate the primary protective responses
to blood stage infections, and have been shown to inhibit
cytoadhesion of infected red blood cells in a domain specific
manner [28,29,37,38,39,40,41,42]. We hypothesize that this type
of immunity would not block infection or preventing transmission
entirely but contribute to parasite removal by preventing
sequestration of parasitized red cells. Under these circumstances,
additional binding domains could provide some residual cytoad-
herent properties even when pre-existing or cross-reactive immune
responses are present, offering a within-host fitness advantage.
Thus, both between- and within-host selection pressures (optimal
binding vs. antigenic diversity) may be operating on var genes in
conflicting ways.
The second important consideration in understanding the
structure of var genes and var gene repertoires is phenotypic
change through the process of antigenic variation. It has long been
recognized that the cytoadhesion phenotype of a particular
malaria parasite exhibits ‘‘plasticity’’ [43], which is likely to
depend on a combination of parasite and host genetics and the
presence of antibodies, and may contribute to the observed age-
and exposure dependent pathologies of malaria. Although the
possibility of displaying different phenotypes in different hosts will
have an important impact on the population structure of var gene
repertoires, most theoretical approaches have so far ignored
phenotypic flexibility. For example, within-host models usually
concentrate on antigenic change during infection [44,45,46,47],
whereas some strain-theoretical, between-host models have
assumed P. falciparum population to consist of discrete phenotypes
in order to explain how the wide range of associations with disease
could be contained within one pathogen population [48,49,50,51].
What remains unclear, however, is how repertoires of var genes
with different phenotypic characteristics have evolved, given that
genes, and thus phenotypes, can be expressed independently.
Here we explore these two aspects of var gene evolution
explicitly through a combination of data analysis and the
development of evolutionary frameworks. First, we analyzed the
var gene repertoires of seven fully sequenced P. falciparum parasite
genomes recently published by Rask et al. [25]. Our analysis
reveals that genetic architectures and domain diversities vary
widely within and between different var gene groups but exhibit a
surprising, non-random association between sequence diversity
and gene length that extends beyond promoter-associated groups.
We then develop an evolutionary framework to demonstrate how
contrasting within- and between-host evolutionary mechanisms
that operate differently at the phenotypic and genotypic level
could have shaped individual domain structures as well as genomic
repertoires of these important virulence genes.
Results
Var domain sequence diversity
As a result of frequent recombination and gene conversion
events, var genes show a high degree of mosaicism [22,52].
Previous analyses have shown that the DBLa domains of UpsA
genes share more sequence mosaics with one another than the
UpsB var genes, suggesting that this group of genes is evolutionary
isolated and more conserved than other groups [21]. Here we
analyzed entire genes, comparing the sequence diversity of all
domains within and between var genes of seven fully sequenced
repertoires. We used the sequence conservation (percent identity)
reported in [25] as a proxy for the population-level diversity of
each subclass of DBL (a, b, c, d and e) and CIDR (a, b, c, d)
domains, since conservation varied considerably within broader
classes. For clarification, we refer to diversity as a measure of
sequence variation whereas frequency is solely used in reference to
the number or prevalence of domains within a gene or population.
Author Summary
Plasmodium falciparum, the most severe of the human
malarias, contains within its genome a family of ,60 var
genes which play an important role in disease pathology
and maintenance of chronic infections. Var genes have a
modular genetic architecture and encode varying numbers
of binding domains with specific preferences to a range of
host tissues. Given the availability of host receptors for
binding and the immunogenic properties of each domain
it is not clear why genes encode multiple domains at once
and how these are structured within each parasite’s
antigenic repertoire. Here we investigate the domain
architecture of these important virulence genes and
highlight an evolutionary trade-off between maintaining
within-host fitness and optimizing between-host transmis-
sion success as an important driver in structuring var
genes and var gene repertoires alike.
Evolution of Multi-Domain Virulence Genes
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To investigate a possible association between the frequency of
domain subclasses and their population-level diversity we plotted
the number of genes that contain a particular subclass against its
sequence conservation for all domain subclasses found in the data
set. As shown in Figure 2 we found a strong negative relationship
(R2 =20.4, P,0.0001) between a domain’s frequency and its
sequence conservation. Note, this negative relationship is inde-
pendent of Ups type and still holds when considering subclasses
associated with UpsA and UpsB/C genes separately (see
Supplementary Figure S1). In agreement with previous analyses
based on the DBLa region only [21] we found that the most
conserved domain subclasses were primarily in UpsA genes and
the most diverse subclasses were found in UpsB genes (with yellow
circles in Figure 2 representing domains found only in UpsA
genes, dark green representing only UpsB or C, and the spectrum
in between representing the proportion found within each group).
Figure 1. Schematic illustrating the hierarchical organization of var domains, genes, and genome repertoires. a) Var genes can be
classified by their chromosomal location and upstream promoter (Ups) type into subtelomeric groups A and B and the central group C. The
proportion of genes belonging to these groups in a parasites genome is well conserved across different isolates, with the majority of genes
belonging to groups B or C (red bars). b) Individual genes are comprised of a varying number of DBL and CIDR domains which mediate binding to
different host receptors in a group-dependent fashion. Both groups (UpsA and non-UpsA) show widely distributed domain architectures; however,
the majority of long genes, i.e. those with .6 domains, belong to group A (blue bars) whereas most B/C genes (red bars) consist of 4 domains. c)
Binding domains can further be divided into various sub-classes and there is extensive variation in terms of frequency and sequence diversity on a
population level.
doi:10.1371/journal.pcbi.1002451.g001
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Importantly, however, there is considerable overlap and both
groups share many domain subclasses with a wide range of
sequence diversities (see Supplementary Materials Figure S1). Bull
et al. [53,54] have previously reported the existence of so called
‘common’ and ‘rare’ PfEMP1 variants, based on their serological
recognition profiles, and these sets of variants are thought to
correspond broadly to UpsA and UpsB or C var genes,
respectively. This is consistent with our finding that UpsA genes,
or rather domains associated with UpsA genes, are on average
more conserved than domains belonging to other Ups groups.
Based on these results we hypothesize a relationship between the
frequency of var gene groups and their average degree of diversity
in the population which is illustrated in the inset in Figure 2.
The fact that UpsA genes appear to be recognized commonly,
but also occur less frequently in the genome and on a population
level, has led to the notion that UpsA genes are preferentially
expressed in young, non-immune individuals, possibly due to an in
vivo growth advantage over other Ups groups. Here we
hypothesized that this type of growth advantage might be
mediated by enhanced parasite binding. This idea is supported
by the fact that group A genes are generally composed of more,
and more conserved binding domains than genes belonging to
groups B or C (Figure 1b), which in turn suggests that the reduced
diversity of group A genes may be due to a functional, i.e. binding,
constraint. We therefore analyzed how domains are grouped into
genes, and how domain diversity is related to var gene length (in
terms of number of domains). Figure 3 shows that longer genes
contain more conserved domains on average, independent of Ups
type. That is, the average sequence conservation of domain
subclasses within a gene increased with the number of domains for
all Ups groups (R = 0.49, P,1610216), suggesting that gene length
might be another useful characterization of var gene groups besides
chromosomal location or upstream promoter type. Importantly,
this relationship also held when considering Ups B’s alone
(R = 0.42, p,1610212). Furthermore, we found that the popula-
tion-level diversity of all domains found within the same gene was
also strongly correlated in a pair-wise fashion, regardless of the
relative positions of those domains (see Table S1 in the
Supplementary Materials).
To further demonstrate these non-random associations between
domain diversities across the genes, we compared the observed
arrangement of domains within var genes to simulated data
generated by randomizing the location of particular domains
across genes but keeping the distribution of gene lengths constant
(see Figure S2 in Supplementary Materials). As expected, the
correlation between gene length and sequence conservation was
not found in the randomized data sets. More importantly, though,
in the randomized data the overall var population diversity was
Figure 2. Relationship between sequence conservation, Ups group, and frequency in the data set for each domain subclass. Each dot
represents a domain subclass, as classified by Rask et al. [25], with the colour of the dot representing the association of that subclass with Ups group
(yellow dots are only found in UpsA var genes, dark green dots are only found in UpsB or C var genes, and intermediate colours are found in all Ups
groups in various proportions). Inset: Hypothetical population distribution of var genes. It has been suggested that UpsA var genes are more
conserved because they are optimized for functionality in naı¨ve individuals, whereas UpsB and C var genes are more prevalent (both in the
population and within var gene repertoires) but more diverse and can sustain infection in individuals with previous exposure [21]. This would lead to
a hypothetical distribution of genes that follows a similar pattern to the domain subclasses observed here. Note that pregnancy associated malaria
var genes (denoted ‘pam’ in the figure) represent an extreme case of this pattern.
doi:10.1371/journal.pcbi.1002451.g002
Evolution of Multi-Domain Virulence Genes
PLoS Computational Biology | www.ploscompbiol.org 4 April 2012 | Volume 8 | Issue 4 | e1002451
decreased, whereas the sequence diversity of domains within an
individual var gene were no longer similar.
Together, these results suggest that var genes are organized such
that domains of similar population-level diversities are grouped
into the same gene. Overall, genes appear to be largely either long
and conserved or short and diverse, independent of Ups type. This
non-random structuring suggests an evolutionary trade-off which
has shaped the var genes on a gene level into those we expect to be
commonly recognized - due to a high number of conserved
domains that facilitate optimal cytoadhesion - and those that may
be rarely recognized because they contain fewer, more diverse
domains and thus appear to be optimized for immune evasion.
Crucially, this trade-off is possible at the gene (rather than the
genome) level because var genes are expressed independently of
each other; for example, a parasite may theoretically express its
UpsA genes in one host and its UpsB or C genes in another. This
phenotypic plasticity means that a single genotype (or gene
repertoire) can simultaneously benefit from a range of different
evolutionary strategies.
The observed domain associations within var genes and the
structure of var gene repertoires open up a number of important
questions: firstly, how are long var genes maintained in the
population given that each additional domain increases the
number of immune targets exposed? And secondly, what
evolutionary processes can explain the non-random domain
structures and genome repertoires described above? Specifically,
how do genomes evolve to include var genes of contrasting
diversities whereas var genes evolve to include domain subclasses
with similar levels of diversity? We developed a series of related
theoretical frameworks to address these questions. In the models
described below we make an important distinction between
pathogen phenotypes, characterized by particular var genes
composed of one or more binding domains, and pathogen
repertoires or genotypes, which may contain multiple var genes
and possible phenotypes.
The evolution of antigens with multiple binding domains
We first examine the conditions leading to the evolution of
multiple antigenic domains. We developed a simple mathematical
model where pathogen phenotypes are defined by antigens
consisting of either one or two binding domains, with each
domain capable of eliciting a protective, allele-specific immune
response (see Methods). We assumed that the primary function of
binding is to reduce parasite clearance and therefore to increase
the duration of infection. We varied the type of allele-specific
immunity in the model between two hypothetical extremes: i) the
traditional assumption in which antibodies to one pathogen
phenotype prevent infection or transmission by phenotypes
sharing domains (via a high degree of cross-immunity, d), and ii)
the cytoadhesion-blocking assumption in which antibodies to a
particular phenotype inhibit binding in a domain-specific manner
and thus reduce transmission of antigenically related phenotypes
by shortening their duration of infection (see Methods).
In our model each domain, denoted A and a, mediates binding
to a different host receptor and comes in a number of antigenically
related alleles, Ai and ai. Assuming three alleles for each domain,
for example, gives rise to a total of 15 possible pathogen
phenotypes: 6 single-domain types (A1, A2, …, a3) plus 9 multi-
Figure 3. Average sequence conservation of domains across genes of different domain-length. Boxplots show the median, 1st and 3rd
quantiles (box limits), and upper and lower bounds for the 95% confidence intervals (whiskers, with dots as outliers) for average conservation (%
identity) of domains occurring across the same var genes of different lengths in the Rask et al. [25] data.
doi:10.1371/journal.pcbi.1002451.g003
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domain types (A1a1, …, A3a3). Figure 4a shows how under the
traditional formulation of cross-immunity, where the price of
sharing antigenic alleles is high due to competition for susceptible
hosts, phenotypes with more than one binding domain are
significantly disadvantaged and outcompeted by those expressing a
single-domain. In contrast, assuming that immunity predominant-
ly prevents binding in a domain-specific manner (Figure 4d), such
that antibodies from previous exposure to A1 do not protect against
infection with A1a1, for example, phenotypes with more than one
binding domain can retain some cytoadhesive properties and thus
gain a competitive advantage over single domain phenotypes. This
leads to the dominance of multi-domain phenotypes in the
population and competitive exclusion of types with only a single
binding domain. If we assume that both categories of immunity
play a (synergistic) role, which is probably the most realistic
scenario for PfEMP1, both single and multi-domain antigens can
coexist. Here, the balance between them will determine the precise
population structure, but in all cases the system evolves towards a
mixed structure of both single and multi-domain phenotypes with
minimal allelic overlap between their antigenic loci (Figure 4b,c).
Note that if we assume that antigen repertoires (i.e. genotypes)
should reflect the population-level structures modelled here, our
results suggest that pathogen genomes should evolve to comprise
genes with varying numbers of binding domains, and could
therefore offer a very simple explanation of the evolution of the
wide distribution of gene lengths observed across var genes from
global isolates (Figure 2). Again, this argument rests on the fact
that individual var genes within a repertoire may be expressed as
independent phenotypes.
The evolution of domain associations and gene
repertoire structures
We next modified our model framework into a stochastic,
individual-based model to accommodate higher degrees of
antigenic and phenotypic diversity (see Methods). This model also
allowed us to move easily between two biological levels of
selections (at the gene and genome level) and to ask whether
similar simple assumptions about immunity can explain the
observed structures and association among (i) domains within
genes (phenotype) and (ii) genes within genomes (genotype).
In this model, each pathogen was comprised of two antigenic
variants. We used the same assumptions about immunological
protection in both the phenotype and genotype models, but we
varied the way in which the two antigenic variants (representing
domains in the first model and genes in the second) jointly
determined pathogen fitness and how it is affected by host
immunity. For the two-domain or phenotype model, we assumed
that the parasite clearance rate is determined by a synergistic
interaction of the constituent binding domains, since the domains
are always expressed together. In contrast, in the two-gene or
genotype model the clearance rate was defined by the gene with
the highest binding affinity to which there were no antibodies, thus
representing the idea of a flexible phenotype. We considered
different domains, or genes, to have different levels of sequence
diversities which determined both binding affinity and cross-
reactivity (i.e. antigenic relatedness). That is, we assumed that
more conserved domains/genes had a within-host advantage, due
to improved cytoadhesion and therefore longer periods of
infections, but were disadvantaged on a population level due to
higher immune selection pressure. Fitness was therefore governed
by the combination of binding domains or genes and balanced by
the trade-off between the within-host and within-population levels
of selection.
Evolution of domain associations
We first analyzed the behaviour of the two-domain represen-
tation, where the fitness of a phenotype within a given infection
depends on both alleles. Figure 5 shows the evolutionary
trajectory and long-term frequency distribution of the various
domain combinations defining phenotypes, assuming 10 alleles
of both high and low diversity at each domain, given a possible
400 different phenotypes in total. For representation purposes
we divided the domains into high affinity groups and low affinity
groups and further classified phenotypes by their combination of
domains according to these groups, resulting in four classes:
phenotypes with two high affinity binding domains, phenotypes
with one high and one low affinity domain (two classes in total),
and phenotypes with two low affinity domains. As illustrated in
the timecourse in Figure 5a, phenotypes with equal domain
diversities (or affinities), i.e. either low-low or high-high
diversity, start to dominate the population over those types
with mixed diversities. Although a competitive advantage of
phenotypes with two high affinity binding domains could be
expected, it is more surprising to also observe a selective
advantage of those comprising two low affinity domains, given
their much reduced within-host fitness compared to phenotypes
with at least one high affinity binding domain. This suggests that
the within-host binding fitness advantaged gained from having
one high affinity domain is immediately outweighed by the
‘antigenic’ costs this imposes onto the phenotype due to the high
level of recognition in the population. In other words,
phenotypes will segregate into those that either maximise
binding or minimise antigenic selection pressure. The domi-
nance of phenotypes with equal levels of diversities is also shown
in the heat map in Figure 5b, which represents the long-term
average prevalence levels of all phenotypes in the population
(with yellow representing high prevalence and dark representing
low prevalence).
The positive correlation between the degrees of diversity of the
two domains, also depicted in the bar chart in Figure 5c, is in
direct agreement with the observed associations in sequence
diversities amongst the binding domains of var genes and thus
corroborates the hypothesis that the evolutionary trade-off
between maintaining high-affinity binding and antigenic diversi-
fication can structure var genes into these non-random domain
combinations.
Evolution of gene repertoire structures
We next examined the dynamics of the two-gene repertoire
model where genotypes exhibited flexible phenotype and clear-
ance rates were determined by the ‘‘most fit’’ gene, dependent on
binding affinity and immune history of the host. Under these
circumstances we observed that the parasite population evolved
towards a structure dominated by genotypes containing both high
and low diversity genes, as shown in the timecourse in Figure 6a.
In contrast to the previous model we now find a negative
association between the levels of diversity of the genes that define a
genotype, i.e. its antigenic and phenotypic repertoire, as illustrated
both as a heat map of the long-term average prevalence of all
genotypes in Figure 6b and as a bar graph of the different
genotype classes in Figure 6c.
The finding that the most successful combination of genes is one
of mixed levels of diversities is in accordance with the observation
that var gene repertoires are generally comprised of a combination
of both conserved (long) and diverse (short) genes. In other words,
whereas domains of equivalent levels of diversity are evolutionarily
favoured at the gene level, a mixture of conserved and diverse
genes are favoured at the repertoire level. In this scenario,
Evolution of Multi-Domain Virulence Genes
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Figure 4. Impact of different mechanisms of immunity on multi-domain structure. Changing the assumption about the nature of
immunity (broadly cross-reactive vs. domain-specific) will select for different combinations of single and multi-domain phenotypes, where each
phenotype is defined by one or two binding domains, A and a, each with three alleles (A1,…, A3, a1, …, a3). Left panel: the dynamics of the proportion
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conserved genes are advantageous in naı¨ve hosts through
increased cytoadhesion whereas diverse genes are selected for in
semi-immune hosts by means of immune evasion. This notion of a
flexible phenotype allows the parasites to benefit from both
strategies. Importantly, our results indicate that changing simple
assumptions about the mechanisms of within-host fitness can
explain the structuring at the level of both the individual gene and
the gene repertoire.
of individuals immune to specific phenotypes over time (each variant is represented by a different colour); right panel: the equilibrium prevalence
distribution of all phenotypes (open bars: single domain types, solid bars: multi-domain types). a) Traditional cross-immunity only, where immunity to
one phenotype confers partial or full immunity to any phenotype sharing alleles, will lead to competitive exclusion of multi-domain types and the
persistence of single domain types. b, c) Assuming both types of immunity acting in synergy leads to dominance of a mixture of single and multi-
domain phenotypes with minimal overlap between their antigenic alleles. d) Adhesion-blocking immunity only, where immunity blocks binding in a
domain-specific and allele-specific manner, will lead to the complete exclusion of single domain phenotypes and the persistence of multi-domain
phenotypes. Parameter values: b= 2, si = 1, m= 1/70, a) d1 = 2, d2 = 2.2, b) d1 = 1.2, d2 = 2, c) d1 = 1.1, d2 = 1.7, d) d1 = 1.2, d2 = 1.5.
doi:10.1371/journal.pcbi.1002451.g004
Figure 5. Evolution of domain associations. a) Simulated timeseries of the different domain combinations grouped by the degree of diversities
of their binding domains shows an evolutionary advantage and dominance of genes whose binding domains have similar levels of diversity (low-low
or high-high). b) Heat map of the long-term average frequency distribution of all possible domain combinations (taken from the last 30 years of the
timeseries in a) showing significantly higher representation of genes with similar domain diversities. c) Bar graph of the long-term (30 year) average
domain diversity associations from all 400 variants in the population showing a positive correlation between the levels of diversity at each binding
domain.
doi:10.1371/journal.pcbi.1002451.g005
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Discussion
The population structure of P. falciparum malaria is shaped by
the interplay of different types of selection pressure on different
epidemiological scales; parasites need to survive within hosts long
enough to ensure transmission while also competing for susceptible
hosts on a population-level. PfEMP1 plays a crucial part in both
these processes because of its role in prolonging infection through
antigenic variation and in the process of naturally acquired
immunity. Our analyses of fully sequenced var gene repertoires
demonstrate that the domain architectures of individual genes as
well as the compositions of genomic repertoires are non-randomly
structured and are maintained despite the high rates of
recombination in P. falciparum. We hypothesised that these
structures are the direct result of opposing selection pressures by
which the parasite has to balance between immune evasion by
means of antigenic diversification and functional integrity through
high affinity iRBC binding. Here we sought to disentangle how
these contrasting levels of selection could have led to the complex
multi-domain gene architectures and var gene repertoires.
Importantly, we have provided a coherent theoretical explana-
tion for the observation that var genes can generally be divided into
genes that are either long and conserved or short and diverse. This
contrasts predictions from traditional multi-strain models, which
posit that parasites should evolve towards minimal antigenic
domain structure (i.e. the fewer antigenic loci exposed the better)
and/or maximal antigenic diversity, and assume that strong
population-level competition is the dominant selective force
Figure 6. Evolution of gene associations. a) Simulated timeseries of the different genotypes grouped by the degree of diversities of their
defining genes shows an evolutionary advantage and dominance of genotypes whose genes have different levels of diversity (low-high or high-low).
b) Heat map of the long-term average frequency distribution of all possible types (taken from the last 30 years of the timeseries in a) showing
significantly higher representation of genotypes with different gene diversities. c) Bar graph of the long-term (30 year) average gene diversity
associations from all 400 variants in the population showing a negative association between the level of diversity of one gene and diversity at the
second gene.
doi:10.1371/journal.pcbi.1002451.g006
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structuring pathogen antigens. We hypothesised instead that
immunity to P. falciparum is partly driven by antibodies which
block cell adhesion in a domain-specific manner, reducing the
parasite’s within-host fitness rather than preventing infection or
transmission per se. Not only does this assumption allow for the
evolution of multi-domain antigenic variants, we also find that the
balance between removal of the parasite by the inhibition of
binding versus the direct killing through antibody-mediated
opsonisation and phagocytosis (as in the classical multi-strain
models) strongly influences the ratio of single to multi-domain
phenotypes in the population.
Our results also show how similar assumptions about immuno-
logical processes acting on genes and genotypes can explain the
observed structures and non-random associations among binding
domains and gene repertoires. Here, synergistic interactions
between domains lead to positively correlated levels of diversity
across genes, whereas the flexible phenotype assumption leads to
the evolution of genomic repertoires with mixed levels of diversity
and a dual life-history strategy.
It has previously been suggested that discrete, independently
circulating strains of P. falciparum may balance trade-offs between
virulence and transmissibility independently [48,49,50,51], with a
small number of ‘‘severe’’ disease-causing, highly transmissible
strains infecting young hosts and numerous ‘‘mild’’, less transmis-
sible strains infecting older hosts. The identification of commonly
recognized isolates associated with severe disease and young host
age seemed consistent with this hypothesis [53,54], although the
complex within-host dynamics of var genes suggested that defining
malaria parasite strains at these loci may be difficult. Flexible
phenotype allows genotypes to benefit from a range of life-history
strategies, however, and the structuring we observed among simple
two-gene repertoires reflected this ability (although we did not
address virulence here): genotypes containing both a conserved
and a diverse gene could optimize function in naı¨ve hosts with one
(group of) gene(s) and escape herd immunity in semi-immune hosts
with another. Thus, rather than discrete strains, var gene
repertoires contain the necessary components to optimize discrete
‘‘common’’ and ‘‘rare’’ phenotypes.
The clear differentiation of binding phenotypes among different
groups of var genes, for example the ICAM1 and CD36 binding
displayed by UpsB/C groups versus CR1 binding in the UpsA
group, has led to the idea that different var genes are specialized for
different ecological niches within the host, which may also define
associated pathologies. It has recently been shown that among
UpsB var genes, long genes are more likely to bind ICAM1 than
short genes [55], suggesting not only that subsets within the Ups
groups exhibit different binding specificities but also that gene
length should be considered as an important sub-classifier of var
genes in addition to promoter type or chromosomal location. This
is further supported by our findings that gene length, or domain
number, is strong and positively correlated with sequence
conservation across genes. A prediction from our model is that
the previously reported association between the expression of Ups
A genes and severe disease in young children [56,57,58,59] could
partly be explained by the overrepresentation of long genes in this
particular group.
It is likely that many other pathogen species face similar
evolutionary trade-offs between within-host growth and between-
host competition. For example, Frank and Bush [60] have
suggested that the measles virus is optimized for high growth
rates among immunologically naı¨ve hosts, but cannot tolerate
escape mutations in response to population-level immune pressure
generated naturally or through vaccination. On the other hand,
the influenza virus is less transmissible and affects a much broader
age class but it benefits from tolerating higher mutation rates to
easily evade herd immunity. Importantly, and in contrast to P.
falciparum, among these pathogens an evolutionary strategy is
associated with a particular genotype. Several bacterial pathogens
exhibit a simplified version of the malaria parasite’s antigenic/
phenotypic variation strategy called phase variation where single
antigenic determinants are expressed in an on/off fashion. For
example, there is some evidence that the phase variable pilus
antigen of the bacteria Streptococcus pneumoniae, which is thought to
enhance colonization and virulence through endothelial binding, is
expressed preferentially in young, immunologically naı¨ve hosts
[61]. This is consistent with the idea that optimizing growth (i.e.
through expression of pilus) may conflict with the need to evade
herd immunity. On the other end of the spectrum, the genome of
the Africa trypanosome Trypanosoma brucei encodes up to 1600
VSG proteins, which form a dense coat around the extracellular
pathogen and shield more conserved proteins against immune
attack. Vsg undergo antigenic variation during infection but are
thought to have no other functional role and can thus exhibit
seemingly unrestricted diversity. The var gene repertoire of P.
falciparum therefore encompasses a range of evolutionary strategies
and constraints, representing a fascinating model system to study
many aspects of host-pathogen evolution that are, on their own,
likely to be common to many pathogens.
There are a number of potential caveats with our approach.
First of all, there might be other functional constraints and
requirements responsible for some of the genes’ domain
architectures, such as structural integrity or synergistic interplays
of multiple domains in mediating effective binding to the same
target cells. Nevertheless, given the huge variety in domain
combinations and domain numbers as well as the range in
sequence conservation across the var genes, it is difficult to imagine
that these are the main or only driving force behind the observed
structures and associations reported here. Secondly, in our models
we only considered a very small number of binding domains or
genes. Although it is easy to argue that the same selection
processes should operate on higher numbers of domains and genes
as well, further research will be required to show this explicitly.
Another important and necessary extension of our work would
be an explicit description of within-host antigenic and phenotypic
variation which should further help to distinguish between in vivo
immune selection, intrinsic gene expression bias and (host niche
dependent) growth advantages. In our framework we only
considered two, antigenically unrelated genes mediating adhesion
to different host receptors, and it will be crucial in the future to
extend this to more genes which compete both on an antigenic as
well as phenotypic level. Clearly, an understanding of the balance
of immune mechanisms that modulate or protect against malaria
infection (e.g. binding inhibition or opsonophagositosis) is also
critical for moving forward, and our models highlight the
important role that these processes play in determining the
outcomes of evolutionary selection. As it stands, our results support
a scenario where a small number of large var genes have a selective
advantage in immunologically naive individuals due to their high
number of relatively conserved binding domains. This advantage,
however, is rapidly lost as individuals acquire a repertoire of
protective antibodies which will consequently lead to the selection
of genes with fewer and antigenically more diverse loci.
Generally, PfEMP1 has not been considered as a vaccine
candidate due to its immense diversity. However, our growing
knowledge about the involvement of individual binding domains
in malaria pathology has started to open up new and exciting
avenues for disease control. Efforts are already under way to
evaluate and optimize var2csa as a target antigen for protecting
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pregnant women against malaria [62,63,64]. This research is
based on the unusual sequence conservation of a subset of its
multiple binding domains. Our results suggest that other domains
to different host receptors might also exhibit conserved features
due to the functional constraints of maintaining high affinity
binding. Importantly, these conserved domains could potentially
be shared by a much larger proportion of the global var gene
reservoir, suggesting that PfEMP1-based vaccines might offer a
realistic addition to ongoing vaccine developments, at least with
regards to protection against the most severe forms of the disease.
Methods
Multi-domain evolution model
We assume a pathogen phenotype, defined by the expression of
a particular gene, to be composed of either one or two receptor-
specific binding domains. Without loss of generality, we denote
domain 1 as mediating binding to receptor 1 (e.g. CR1) and
domain 2 as mediating binding to receptor 2 (e.g. CD36). We
further assume that each domain has a number of alleles, denoted
Ai and ai at binding domain 1 and 2, respectively. The dynamics
and evolutionary trajectory of each phenotype i, carrying either a
single or a two binding domains, can then be described by
dividing the host population into a number of overlapping
compartments: zi, the proportion that has been exposed and is
now immune to phenotype i; x1,2i , the proportion of individuals
that have been exposed and are now immune to any phenotypes
which share either one or two binding domains that constitute
phenotype i (x1i and x
2
i , respectively); wi, the proportion of the
population exposed and immune to all phenotypes that share any
alleles with phenotype i; and finally w1,2i , the proportion exposed
and immune to phenotypes which share particular alleles at
domain 1 or at domain 2 (w1i and w
2
i , respectively). Note, under
this set-up, w1i and w
2
i are subsets of wi, for example, and x
2
i is a
subset of x1i .
The rate of change in these compartments can then be
described by the following set of differential equations for each
phenotype i:
dzi
dt
~li 1{zið Þ{mzi
dx1,2i
dt
~
X
l
ll 1{x
1,2
i
 
{mx1,2i
dwi
dt
~
X
j
lj 1{wið Þ{mwi
dw1,2i
dt
~
X
k
lk 1{w
1,2
i
 
{mw1,2i ,
where the force of infection is given as li~byi, and 1=m is the
average host life-expectancy. The dynamics of the population
currently infected and infectious with single domain phenotypes is
given as
dyi
dt
~li 1{wið Þ{ sLi zm
 
,
whereas for multi-domain phenotypes we use
dyi
dt
~li 1{zi{Dið Þ{ sLi zm
 
,
with 1=sLi as the duration of infection of phenotype i, dependent
on immune history Li. The reason for this distinction is that a
single-domain phenotype can only infect hosts with no previous
exposure to this particular allele (this is the proportion 12wi),
whereas multi-domain phenotypes can make use of their
alternative binding domain and hence infect all hosts except those
with previous exposure to both alleles that define phenotype i,
which can be found as 1{zi{Di, with Di~wi{zi{ (wi{w
1
i )z

(wi{w
2
i )Þ. In other words, we assume that immunity is allele
specific such that antibodies to Ai block adhesion of domain 1 in
phenotypes carrying the Ai allele and partially block adhesion of an
alternative allele, Aj, but do not inhibit cell-adhesion mediated by a
potential second domain. Adhesion of phenotypes defined by Aiai
will therefore not be inhibited by adhesion-blocking antibodies to
just Ai; on the other hand, independent exposure to alleles Ai and aj
will give full protection against phenotype Aiaj.
As we do not have explicit information about the immune
history of each individual host we calculate the clearance rate as a
population average as follows:
sLi~
si
1{wi
1{x1izd1 x
1
i{wi
  
for single domain phenotypes, and
sLi~
s
1{zi{Di
1{x1i{Dizd1 x
1
i{x
2
i
 
zd2 x
2
i{zi
  
for multi-domain phenotypes, where s is the base clearance rate.
This means that we average the clearance rate over the proportions
of the population that have not been exposed to phenotypes with
any shared domains (e.g. 1{x1i in the single domain case) and those
that have been exposed to phenotypes with either one or two shared
binding domains (e.g. x1i{wi, in the single domain case), which are
subjected to a degrees of cross-immunity, d1 (and d2, for multi-
domain phenotypes, with d2§d1§1).
Individual-based model
As in the deterministic models we define a genotype or phenotype
by two antigenic alleles, either representing individual domains or
individual genes, which mediate binding to different host receptors.
We further assume that each domain or gene has a number of alleles
with different degrees of (sequence) diversity that determine both
binding affinity and antigenic similarity. That is, more conserved
alleles are assumed to have a higher binding specificity/affinity but
also suffer from a higher degree of cross-inhibition. Antibodies against
a low diversity, high-affinity allele therefore block adhesion of any of
the other high-affinity alleles to a much higher degree than antibodies
against a low-affinity allele, and vice versa. In addition to inhibiting
cell adhesion, we also assumed cross-immunity to operate by direct
killing of phenotypes or genotypes with shared or antigenically similar
domains, e.g. through phagocytosis or opsonisation, albeit to a
smaller extent. The within-host fitness of a pathogen is therefore
dependent both on the binding affinities of its antigenic loci and
immune-mediated inhibition (i.e. the immune history of the host).
We considered two different scenarios: one in which phenotypes
were defined by two binding domains, and one in which genotypes
were defined by two antigenic loci. These two scenarios are simply
distinguished by the assumption made about how immunity
mediates clearance rates. In the phenotype model, both domains
act synergistically in determining the gene’s fitness in terms of
infection length, schematically given as length~k affinitydomain1:ð
inhibitiondomain1zaffinitydomain2:inhibitiondomain2Þ, where k
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is a positive constant. In contrast, in the genotype model,
each gene is assumed to act independently and the pathogen’s
within-host fitness is thus defined by the fittest gene and can be
given as length~max affinitydomain1:inhibitiondomain1,affinitydomain2:ð
inhibitiondomain2Þ. Although this at first might seem a crude
assumption, for a low number of genes it is more realistic than
assuming genes are being expressed in order and also more in line with
a previous model of antigenic variation [46], especially as we assume no
inherent immunological inhibition between the two genes.
Assuming n high-affinity and m low-affinity alleles at each of the
two domains or genes, there were a total of D~ nzmð Þ2
phenotypes/genotypes that are maintained in the population through
recombination and occasional re-introduction to counter stochastic
extinction events. We do not explicitly take into account the mosquito
population but instead assume that transmission is proportional to the
number of individuals infected with any of the D possible pathogens.
We allow super-infection but for simplicity assume that infections are
independent of each other, i.e. there is no within-host competition
and infection length (transmissibility) is dependent only on the
infecting phenotype/genotype and the host’s previous immune
repertoire. A list of parameter values and their definition can be
found in Table S2 in the Supplementary Materials.
Supporting Information
Figure S1 Relationship between frequency of occur-
rence and sequence conservation among domain sub-
classes found in Ups A genes (above) and Ups B/C genes
(below). Although there is considerable overlap between groups
(see Figure 2 in main text) there are domain subclasses unique to
each group. The negative correlation between frequency and
conservation is stronger among Ups B/C genes (R=20.34,
p = 0.0002), it is still significant among Ups A only domain
subclasses (R=20.28, p= 0.012). Note that we have removed
outliers that occur in over 100 genes; these are extremely diverse
and would exaggerate the correlation.
(TIF)
Figure S2 Randomization results from 10,000 simulat-
ed data sets, where the simulated gene lengths were the
same as in the data but the domains were randomized
across genes. a) The distribution of correlation coefficients
between gene length and average domain conservation for
randomizations of the data (mean R = 0.01, 20.12:0.09 5th:95th
percentiles), with the real value (R = 0.49) indicated by the arrow.
b) The variance in population level diversity of var genes (using
mean conservation across genes) for the randomized data (mean
s2 = 23, 21:29 5th:95th percentiles) compared with the real value
(s2 = 37) indicated by the arrow. c) The variance in the
conservation of domains within particular genes for the
randomized data (mean s2 = 106.8, 103:111 5th:95th percentiles),
with the real value (s2 = 94) indicated by the arrow. All
distributions are highly significantly different from the observed
value.
(TIF)
Table S1 Pairwise correlation coefficients of the per-
cent identity of domains at different positions within the
same gene. Starred numbers are highly significant (P,1E-5)
following a Bonferroni correction for multiple comparisons. The
purpose of this analysis is simply to show that the correlation
between domains across individual genes is not simply driven by
the strong relationship between particular domain combinations
(for example, the head structure containing the first DBL and
CIDR domains).
(DOCX)
Table S2 Parameter values and range used in the
individual-based framework.
(DOCX)
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